Alan Auerbach
Medicine

Alan Auerbach Net Worth

Alan Auerbach is a successful American entrepreneur who has achieved two major successes in the biotech sector. In 2009, Johnson & Johnson purchased Cougar Biotechnology, a cancer drug company founded by Auerbach, for approximately $1 billion in cash, netting Auerbach an estimated $50 million. In 2014, shares of his latest business, Puma Biotechnology, skyrocketed following positive news from a late stage clinical trial of a breast cancer drug. Auerbach holds a bachelor's and master's degree in biomedical engineering and began his career as a research analyst covering biotech companies in Los Angeles.
Alan Auerbach is a member of Medicine

Age, Biography and Wiki

Birth Place United States

💰 Net worth: $1.2 Billion (2024)

Alan Auerbach's net worth is estimated to be $1.2 billion in 2024. He is widely recognized as a prominent figure in the field of medicine in the United States. Known for his contributions to the healthcare industry, Auerbach has earned significant wealth through his successful career. His expertise and groundbreaking work have undoubtedly played a crucial role in shaping the medical landscape, offering innovative solutions and advancements to enhance patient care. With his remarkable net worth, Alan Auerbach continues to make a lasting impact in the field of medicine, revolutionizing the way we approach healthcare.

2014 $1.55 Million
2015 $1.2 Million
2018 $1.2 Million

Biography/Timeline

1992

Auerbach is a fellow of the American Academy of Arts and Sciences and of the Econometric Society. He was the Deputy Chief of Staff of the U.S. Join Committee on Taxation in 1992.

Some Alan Auerbach images

About the author

Lisa Scholfield

As a Senior Writer at Famous Net Worth, I spearhead an exceptional team dedicated to uncovering and sharing the stories of pioneering individuals. My passion for unearthing untold narratives drives me to delve deep into the essence of each subject, bringing forth a unique blend of factual accuracy and narrative allure. In orchestrating the editorial workflow, I am deeply involved in every step—from initial research to the final touches of publishing, ensuring each biography not only informs but also engages and inspires our readership.